共 50 条
- [1] Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trialBMC MEDICINE, 2013, 11Bailey, Clifford J.Gross, Jorge L.Hennicken, DelphineIqbal, NayyarMansfield, Traci A.List, James F.
- [2] Erratum to: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trialBMC Medicine, 11Clifford J BaileyJorge L GrossDelphine HennickenNayyar IqbalTraci A MansfieldJames F List
- [3] Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial (vol 11, pg 193, 2013)BMC MEDICINE, 2013, 11Bailey, Clifford J.Gross, Jorge L.Hennicken, DelphineIqbal, NayyarMansfield, Traci A.List, James F.
- [4] Pioglitazone as Add-on Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled TrialDIABETES & METABOLISM JOURNAL, 2024, 48 (05)Heo, Ji HyeHan, Kyung AhHong, Jun HwaSeo, Hyun-AeHong, Eun-GyoungYu, Jae MyungJung, Hye SeungCha, Bong-Soo
- [5] Henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trialDIABETES OBESITY & METABOLISM, 2021, 23 (08): : 1754 - 1764Weng, JianpingZeng, LongyiZhang, YuweiQu, ShenWang, XueyingLi, PingFu, LiujunMa, BoqingYe, ShandongSun, JiaoLu, WeipingLiu, ZhiwenChen, DaoxiongCheng, ZhifengLiu, HaiyanZhang, TaoZou, Jianjun
- [6] Retagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trialDIABETES OBESITY & METABOLISM, 2024, 26 (07): : 2830 - 2838Guo, LixinTian, FengshengLiu, LiChen, MingweiJiang, ChengxiaLi, ShuangqingLiu, CongZhang, YaweiQin, JieYu, DongniZong, YicenDai, Wei
- [7] Efficacy and safety of pioglitazone add-on in patients with type 2 diabetes inadequately controlled with metformin and dapagliflozin: a randomised, double-blind, and placebo-controlled studyDIABETOLOGIA, 2024, 67 : S322 - S323Cho, Y.Kim, K. -S.Lee, B. -W.Hong, J.Yu, J.Lim, S.Kim, Y.Lee, C.Kim, S.Kwak, S.Lee, W.
- [8] Efficacy and Safety of Pioglitazone Add-on in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin and Dapagliflozin: A Multicenter, Randomized, Double-blind, and Placebo-controlled StudyCLINICAL THERAPEUTICS, 2024, 46 (09) : 662 - 669Cho, Yun KyungKim, Kyung-SooLee, Byung-WanHong, Jun HwaYu, Jae MyungLim, SooKim, Ye AnLee, Chang BeomKim, Sang SooKwak, Soo HeonLee, Woo Je
- [9] Empagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Placebo-Controlled TrialDIABETES CARE, 2014, 37 (06) : 1650 - 1659Haering, Hans-UlrichMerker, LudwigSeewaldt-Becker, ElkeWeimer, MarcMeinicke, ThomasBroedl, Uli C.Woerle, Hans J.
- [10] Efficacy and safety of dapagliflozin monotherapy in people with Type 2 diabetes: a randomized double-blind placebo-controlled 102-week trialDIABETIC MEDICINE, 2015, 32 (04) : 531 - 541Bailey, C. J.Villegas, E. C. MoralesWoo, V.Tang, W.Ptaszynska, A.List, J. F.